| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 1 | 1 | 1 | 1 | 4 | 2 | 1 | 0 | 1 | 1 | 1 | 1 |
| Expenses | 2 | 1 | 2 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | -1 | -0 | -1 | -2 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Operating Profit % | -163 % | -10 % | -46 % | -228 % | 4 % | 7 % | -91 % | -118 % | -3 % | 6 % | 12 % | 7 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | -2 | -1 | -2 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -2 | -2 | -1 | -2 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| EPS in ₹ | -1.42 | -2.04 | -0.48 | -2.22 | 0.11 | 0.08 | -0.92 | -0.50 | -0.04 | 0.06 | 0.10 | 0.00 |
Hindustan Bio Sciences
Hindustan Bio Sciences
5.70
-0.30
(-5.00%)
Market Cap
₹- Cr
PE Ratio
-
Volume
16,430.00
Day High - Low
₹6.18 - ₹5.70
52W High-Low
₹11.73 - ₹5.80
Key Fundamentals
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
0.84
EBITDA
-
Dividend Yield
- %
Industry
Information Technology Sector
Software Products ROE Growth %
-
Debt to Equity
-
Actual
Company News
View All News
Hindustan Biosciences Limited reported a loss of Rs 5.85 lakhs for the quarter ended September 30, 2025, compared to a profit of Rs 1.40 lakhs in the previous quarter. Revenue from operations dropped to Rs 32.19 lakhs from Rs 42.54 lakhs in the comparable period. For the half-year period, the company posted a loss of Rs 4.45 lakhs. Total expenses decreased to Rs 6.71 lakhs from Rs 32.41 lakhs in the previous quarter. The company's cash and cash equivalents stood at Rs 1.63 lakhs. Employee benefit expenses were Rs 4.96 lakhs for the quarter. The Board of Directors approved these unaudited standalone financial results in their meeting held on October 31, 2025.
Hindustan Bio Sciences Reports Quarterly Financial Results for June 2025Aug 04, 2025
Hindustan Bio Sciences Ltd published its unaudited financial results for the quarter ended June 30, 2025, in compliance with regulatory requirements. The company reported total income of ₹32.19 lakhs compared to ₹41.11 lakhs in the same quarter last year. Net profit after tax stood at ₹1.40 lakhs versus ₹8.18 lakhs in the previous year quarter. The company operates in the pharmaceutical trading segment. Results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on July 31, 2025, with statutory auditors expressing an unmodified audit opinion.
Hindustan Biosciences Ltd. reported quarterly results showing revenue from operations of Rs 32.19 lakhs and profit of Rs 1.40 lakhs for the quarter ended June 30, 2025. The company announced the resignation of Company Secretary Devanshu Ravinder Dange due to personal reasons, effective July 31, 2025. Shailendra Vyas has been appointed as the new Company Secretary, Key Managerial Personnel and Compliance Officer from August 1, 2025. The board approved the notice for the 33rd Annual General Meeting scheduled for September and adopted the Secretarial Audit Report. VBSS Prasad was appointed as scrutinizer for e-voting at the upcoming AGM.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
586.50 | - | #1 - | - | - | - | - | 49.36 | |
51.85 | - | #1 - | - | - | - | - | 41.93 | |
123.35 | - | #1 - | - | - | - | - | 38.51 | |
292.35 | - | #1 - | - | - | - | - | 37.38 | |
162.65 | - | #1 - | - | - | - | - | 46.25 | |
71.15 | - | #1 - | - | - | - | - | 49.07 | |
11.89 | - | #1 - | - | - | - | - | 38.47 | |
124.11 | - | #1 - | - | - | - | - | 46.70 | |
310.40 | - | #1 - | - | - | - | - | 41.12 | |
557.80 | - | #1 - | - | - | - | - | 32.28 |
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 8 | 6 | 6 | 4 | 6 | 6 | 4 | 3 | 3 | 3 | 3 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1 | 1 | 1 | 0 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Capital Work in Progress | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 6 | 6 | 4 | 6 | 6 | 3 | 3 | 3 | 3 | 3 |
| Total Liabilities | 8 | 6 | 6 | 4 | 6 | 6 | 4 | 3 | 3 | 3 | 3 |
| Current Liabilities | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 |
| Non Current Liabilities | 1 | 0 | 1 | 1 | 3 | 2 | 1 | 1 | 1 | 3 | 3 |
| Total Equity | 7 | 5 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Reserve & Surplus | -3 | -5 | -6 | -8 | -8 | -8 | -9 | -10 | -1 | -1 | -1 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 2 | 2 | 2 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Activities | -0 | 1 | -0 | -0 | -1 | 1 | 1 | -0 | -0 | -1 | 0 |
| Financing Activities | 0 | -1 | 0 | 0 | 2 | -1 | -1 | 0 | 0 | 1 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % | 12.19 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 83.52 % | 83.51 % | 83.55 % | 83.38 % | 83.71 % | 83.82 % | 83.68 % | 83.83 % | 83.09 % | 83.85 % | 83.71 % | 84.01 % | 84.00 % | 84.06 % | 84.08 % | 84.04 % | 84.02 % | 84.02 % | 81.68 % |
| Others | 4.29 % | 4.30 % | 4.26 % | 4.43 % | 4.10 % | 3.99 % | 4.13 % | 3.98 % | 4.72 % | 3.96 % | 4.10 % | 3.80 % | 3.81 % | 3.75 % | 3.73 % | 3.77 % | 3.79 % | 3.79 % | 6.13 % |
| No of Share Holders | 7,033 | 7,655 | 7,937 | 8,385 | 8,777 | 8,766 | 8,798 | 8,879 | 8,793 | 8,853 | 9,253 | 10,315 | 10,921 | 11,779 | 11,618 | 11,276 | 11,246 | 11,620 | 11,405 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Dec 2023 |  Extraordinary General Meeting | NA | 29 Dec 2023 | 9.12 | 8.84 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 7.56 | 8.67 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 10.57 | 11.40 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 9.89 | 9.32 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 7.66 | 10.32 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 9.03 | 8.90 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 8.90 | 8.05 |
| 31 Oct 2025 | Quarterly Result Announcement | NA | 31 Oct 2025 | 8.49 | 7.14 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 03, 2025
Nov 03, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 31-10-2025Oct 31, 2025
Oct 31, 2025Board Meeting Intimation for Consider The Unaudited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30 2025 Along With Limited Review ReportOct 16, 2025
Oct 16, 2025Special Window For Re-Lodgment Of Transfer Request Of Physical Shares Pursuant To SEBI Circular Dated July 2 2025Oct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Special Window For Re-Lodgment Of Transfer Requests Of Physical Shares Pursuant To SEBI Circular Dated July 2 2025Sep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025AGM To Be Held On 30-09-2025Aug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJul 31, 2025
Jul 31, 2025Appointment of Company Secretary and Compliance OfficerJul 31, 2025
Jul 31, 2025Un-Audited Standalone Financial Results For The First Quarter Ended On June 30 2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday July 31 2025 As Required Under Regulation 30 Of SEBI (LODR) 2015Jul 31, 2025
Jul 31, 2025Board Meeting Intimation for Considering The Un-Audited Standalone Financial Results Of The Company For The First Quarter Ended On June 30 2025.Jul 19, 2025
Jul 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 17, 2025
Jul 17, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Jun 07, 2025Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of Internal AuditorMay 30, 2025
May 30, 2025Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of Secretarial AuditorMay 30, 2025
May 30, 2025Audited Standalone Results And Statements For The Fourth Quarter And Financial Year Ended On March 31 2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 30 2025 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 24, 2025
May 24, 2025Board Meeting Intimation for Considering The Audited Standalone Results For The Quarter And Financial Year Ended On March 31 2025May 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2025
Apr 23, 2025Appointment of Company Secretary and Compliance OfficerApr 23, 2025
Apr 23, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday April 23 2025 - Appointment Of Mr. Devanshu Ravinder Dange As Company Secretary And Compliance Officer.Apr 23, 2025
Apr 23, 2025Reg. 40(10) PCS Certificate For The Year Ended 31-03-2025 Apr 18, 2025
Apr 18, 2025Non-Applicability Of Criteria Of Large Corporate - Initial DisclosureApr 18, 2025
Apr 18, 2025Reg. 7(3) Compliance Certificate For The Year Ended 31St March 2025Apr 16, 2025
Apr 16, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 15, 2025
Apr 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Apr 15, 2025Disclosures Under Regulation 31 (4) Of SEBI (SAST) Regulations 2011Apr 08, 2025
Apr 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Integrated Filing (Financial)Mar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Feb 05, 2025Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2025
Jan 30, 2025Board Meeting Intimation for Intimation Of Board MeetingJan 20, 2025
Jan 20, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Jan 10, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 31, 2024
Dec 31, 2024Closure of Trading WindowDec 31, 2024
Dec 31, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2024
Nov 05, 2024Board Meeting Outcome for Outcome Of Board MeetingOct 30, 2024
Oct 30, 2024Board Meeting Intimation for Intimation Of Board MeetingOct 17, 2024
Oct 17, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Oct 10, 2024Technical Indicators
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
